Pharmacotherapy Publishing Inc
View my basket
Atypon Link logo

You have no access to this article

Osteoporosis Screening and Education in Community Pharmacies Using a Team Approach


Author(s): Eric J. MacLaughlin | Anitra A. MacLaughlin | Kathleen A. Snella | Thomas S. Winston | David S. Fike | Cynthia R. Raehl
doi: 10.1592/phco.25.3.379.61604
Prev | Table of contents | Next
 
View PDF article (83 K) View references
Email this link
 What is RSS?
Trouble viewing articles as PDF?
 
  Pharmacotherapy
 
Print ISSN: 0277-0008
Volume: 25 | Issue: 3
Cover date: March 2005
Page(s): 379-386
 
 
  Key Words
 
osteoporosis, osteopenia, peripheral screening, quantitative ultrasound, bone mineral density, dual x-ray absorptiometry, pharmacy
 
  Abstract

Study Objectives. To develop a model for osteoporosis screening and education in community pharmacies using a team approach, compare bone mineral density T-scores between quantitative ultrasound (QUS) and dual-energy x-ray absorptiometry (DXA), and determine patient satisfaction with this pharmacist-provided osteoporosis screening and education program.

Design. Prospective, cross-sectional study.

Setting. Community pharmacies and outpatient family medicine, internal medicine, and obstetrics and gynecology clinics in Amarillo, Texas.

Patients. Women aged 55 years or older with no previous diagnosis of osteoporosis or osteopenia who had at least one additional risk factor for osteoporosis and had not been screened in the previous 3 years.

Intervention. Patients were referred from family medicine, internal medicine, and obstetrics and gynecology clinics to a community pharmacy. Osteoporosis screening using heel QUS and education regarding disease prevention and treatment were provided by pharmacists. Screening results, recommendations for confirmatory DXA, and potential treatments options were provided to the referring physicians.

Measurements and Main Results. A total of 100 patients (mean age 66.2 ± 7.9 yrs) were enrolled in the study; three were subsequently excluded. Of the 97 study patients who were screened using QUS, 45 (46%) patients were at moderate risk (T-score < −1 to > −2.5) and nine (9%) were at high risk (T-score ≤ −2.5). Of 54 patients recommended for DXA referral, 20 (37%) completed the scan. All 20 were diagnosed with either osteopenia (9 patients [45%]) or osteoporosis (11 patients [55%]). Correlation was moderate between T-scores obtained by QUS and DXA of lumbar vertebrae 1–4 (r=0.45, p=0.026). Counseling regarding risk factors, screening results, smoking cessation, calcium intake, exercise, and caffeine intake was perceived by patients as valuable or highly valuable (medians for all items ranged from 4–5 on a 5-point Likert scale). Of 84 patients assessed (13 were lost to follow-up), 81 (96%) said they would recommend this service to others.

Conclusion. Osteoporosis screening and education in community pharmacies are effective in detecting undiagnosed disease and are perceived by patients as highly useful.

 
  Author(s) affiliations
 
1. Department of Pharmacy Practice, School of Pharmacy, Department of Family and Community Medicine, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas.
Address reprint requests to Eric J. MacLaughlin, Pharm.D., BCPS, Department of Pharmacy Practice, Texas Tech School of Pharmacy, 1300 Coulter Drive, Amarillo, TX 79106-1712; e-mail: Eric.MacLaughlin@TTUHSC.EDU.
2. Walgreens Pharmacy, Amarillo, Texas.
3. Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas.
4. Department of Family and Community Medicine, School of Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas.
5. Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas., Division of Sciences and Engineering, Amarillo College, Amarillo, Texas.
6. Department of Pharmacy Practice, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas.
 
  This article has been cited by:
1.
 
Osteoporosis Risk in Premenopausal Women.
Sheryl F. Vondracek, , Laura B. Hansen, , Michael T. McDermott, .
Pharmacotherapy |  29 |  3 |  305-317
View Header/Abstract | View PDF article (210 KB) | PDF Plus (214 KB) 
2.
 
Pharmacists’ Interventions for Optimization of Medication Use in Nursing Homes.
Charlotte L R Verrue, Mirko Petrovic, Els Mehuys, Jean Paul Remon, Robert Vander Stichele.
Drugs & Aging |  26 |  1 |  37-49
CrossRef